Skip to main content

Table 1 Demographic and clinical characteristics of patients involved in the study

From: A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

Subjects

HD

BPH/Prostatitis

Prostate Cancer

 

n = 124

n = 121

n = 131

Age (year)

   

unknown

124

2

4

<40

 

2

1

40-49

 

4

2

50-59

 

16

2

60-69

 

30

14

70-79

 

46

38

>80

 

21

20

Collection site*

   

Japan

84

121

81

U.S.

40

0

50

Gleason Scores

   

unknown

  

10

< and = 6

  

61

7

  

29

> and = 8

  

31

  1. *Race is not known, samples are only classified based on the collection site. Note that this pilot study is focused on comparing A+PSA with the PSA assay, cohort size was not sufficient to match samples according to potential clinical co-founders.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us